In addition to the increased mortality data we provide here, CRP levels are associated with venous thromboembolic disease in COVID-19 with the worst outcomes seen in patients with high CRP and D-dimer concentrations (Smilowitz et al., 2021). This evidence concerns the gene CRP and venous thromboembolism.